RxDoctor Payments Data

Chirayu Patel, MD

Radiation Oncology · Boston, MANPI 1700128295

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $4,200 of the $4,200 with a category attached, or 100.0%. Every reported general payment came from a single manufacturer, Novartis Pharma AG.

$4,200in general payments, 2019–2025

Across 1 payment — averaging $4200.00 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novartis Pharma AG$4K
$151,900in research payments, 2019–2025

Across 3 payments — averaging $50,633 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Siemens Medical Solutions USA, Inc.$152K

What the payments were for

  • Consulting fees$4,200100%

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Novartis Pharma AG1$4,200

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,200 in reported general payments places this provider in the 85th percentile of 200 radiation oncology providers in Massachusetts.

See all radiation oncology providers in Massachusetts

Medicare billing

Part B allowed, 2024
$199,574
Medicare patients
249
Services billed
2,066

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other radiation oncology in Boston

See the full list for Massachusetts

Where these figures come from

Is this you, or does something look wrong? →